The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug for advanced s...
Replimune's drug for advanced skin cancer fails to win FDA nod again
The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug for advanced skin cancer, citing insufficient data from studies,...
Author: Reuters
Read Original Article